Loading
DFP-14323 is an experimental small molecule from Delta-Fly Pharma, at a stage the company does not state for lung cancer; its current status is not stated.
DFP-14323 is a small molecule (oral; low-dose ubenimex, also called bestatin) from Delta-Fly Pharma, with Nippon Chemiphar as licensee. Low-dose ubenimex (bestatin), a protease inhibitor, which the company says has stronger anti-tumour effect and improves immune function; presented with an EGFR inhibitor in lung cancer. The company does not state its stage; it is aimed at lung cancer. No clinical trial naming it is registered on ClinicalTrials.gov. Stage not stated in the page text (the status chart is an image). No ClinicalTrials.gov record found; Japanese registries (jRCT) were not searched. It has not been shown to work in people.
Low-dose ubenimex (bestatin), a protease inhibitor, which the company says has stronger anti-tumour effect and improves immune function; presented with an EGFR inhibitor in lung cancer.
1.DFP-14323 slips into a pocket on its target.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"DFP-14323" OR ABSTRACT:"DFP-14323") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about DFP-14323, not a curated reading list.
Shares Delta-Fly Pharma and the tag pipeline.
Shares Delta-Fly Pharma and the tag pipeline.
Shares Delta-Fly Pharma and the tag pipeline.
Shares Delta-Fly Pharma and the tag pipeline.
Shares Delta-Fly Pharma and the tag pipeline.
Shares Delta-Fly Pharma and the tag pipeline.
Shares Delta-Fly Pharma and the tag pipeline.
Shares Delta-Fly Pharma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/